Form 4: Cardio Diagnostics Director Acquires Future Stock Options

Cardio Diagnostics Holdings Director Paul Frederick Burton reported the acquisition of 2,306 stock options with an exercise price of $2.71, exercisable from December 31, 2025, and expiring in 2035.

Summary

• Paul Frederick Burton, a Director of Cardio Diagnostics Holdings, Inc. (CDIO), reported a transaction involving derivative securities.
• The transaction, made pursuant to a Rule 10b5-1 plan, involves the acquisition of stock options on December 31, 2025.
• A total of 2,306 stock options were acquired, each representing the right to buy one share of common stock.
• The exercise price for these options is $2.71 per share.
• These options become exercisable on December 31, 2025, and will expire on December 31, 2035.
• Following this reported transaction, Paul Frederick Burton beneficially owns 7,259 derivative securities.

Sentiment

Score: 7

Explanation: The acquisition of stock options by a director, particularly when executed under a pre-arranged Rule 10b5-1 plan, generally signals a pre-existing confidence in the company's future performance and potential for stock price appreciation, which is a positive indicator for investors.

Positives

• The acquisition of stock options by a director, especially under a Rule 10b5-1 plan, can signal management's pre-planned confidence in the company's long-term growth and stock performance.

Negatives

• No explicit negative information is contained within this insider transaction report.

Risks

• No specific risks are detailed in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain explicit forward-looking statements or guidance from the company. It reports an insider's equity transaction.

Industry Context

This Form 4 filing is specific to an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: May view the director's acquisition of options as a positive signal of alignment with shareholder interests and confidence in future growth.

Key Dates

Keywords

Cardio Diagnostics Holdings, CDIO, Form 4, Insider Transaction, Stock Options, Director, Paul Burton, Equity Grant, Beneficial Ownership, Future Transaction, Rule 10b5-1 Plan